Covered recipient · General Payments record
MELISSA DAWN CAIN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2024
$125.25
- Reported across 8 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $125.25 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $46.47 | 3 |
| Novo Nordisk AS | $20.32 | 1 |
| Janssen Pharmaceuticals, Inc | $15.97 | 1 |
| Paratek Pharmaceuticals, Inc. | $15.25 | 1 |
| GlaxoSmithKline, LLC. | $13.97 | 1 |
| Acerta Pharma LLC | $13.27 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $125.25 | 8 |
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $13.27 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104632150 | CMS |
| GlaxoSmithKline, LLC. | $13.97 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116443347 | CMS |
| Janssen Pharmaceuticals, Inc | $15.97 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078073594 | CMS |
| Lilly USA, LLC | $14.20 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135745836 | CMS |
| Lilly USA, LLC | $18.96 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135821403 | CMS |
| Lilly USA, LLC | $13.31 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135830473 | CMS |
| Novo Nordisk Inc | $20.32 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100375063 | CMS |
| Paratek Pharmaceuticals, Inc. | $15.25 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113925968 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.